Prognosis in colorectal cancer beyond TNM
Open Access
- 1 December 2020
- journal article
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 40 (04) , 404-411
Abstract
Introduction Colorectal cancer is one of the neoplasms with the greatest social impact. Given the great molecular heterogeneity and diversity of pathophysiological mechanisms, it is difficult to define prognostic factors that could guide therapy. Objectives To identify the molecular prognostic factors that may be of interest in clinical practice and to synthesize the existing evidence. Material and methods The search for the articles was carried out using the PubMed platform and the keywords “sporadic colorectal cancer and prognosis”, for articles published between 2014 and 2019. We selected all articles published on studies in humans and written in English or Portuguese. Of the 215 articles found, 35 articles were selected to perform this review. Results Current evidence supports the use of four molecular markers in clinical practice − KRAS, NRAS and BRAF (EGFR signalling pathway) and the mismatch repair status. Conclusion The use of molecular biomarkers in clinical practice to define prognosis is still little supported by the existent evidence. The studies are slightly contradictory, so new projects and international collaborations must be carried out in this area to obtain more robust evidence.Keywords
This publication has 38 references indexed in Scilit:
- Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic reviewClinical Epigenetics, 2018
- Clinicopathological, genomic and immunological factors in colorectal cancer prognosisBritish Journal of Surgery, 2018
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerInternational Journal of Molecular Sciences, 2017
- The evolving role of microsatellite instability in colorectal cancer: A reviewCancer Treatment Reviews, 2016
- Methylator phenotype in colorectal cancer: A prognostic factor or not?Critical Reviews in Oncology/Hematology, 2016
- Colorectal cancerNature Reviews Disease Primers, 2015
- Microsatellite instability in colorectal cancer: clinicopathological significancePolish Journal of Pathology, 2015
- Genetics and Genetic Biomarkers in Sporadic Colorectal CancerGastroenterology, 2015
- Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancerBritish Journal of Cancer, 2015
- Molecular markers for colon diagnosis, prognosis and targeted therapyJournal of Surgical Oncology, 2014